The JAK2V617F mutation is a target for specific T cells in the JAK2V617F-positive myeloproliferative neoplasms

Research output: Contribution to journal › Letter › Research › peer-review

Original languageEnglish
JournalLeukemia
Volume31
Pages (from-to)495-498
ISSN0887-6924
DOIs
Publication statusPublished - 2017

ID: 174662597